Utama › Leukemia Mieloid Akut › New Jersey › Edison
Kajian klinikal Leukemia Mieloid Akut di Edison, NJ
20 kajian untuk Leukemia Mieloid Akut sedang mencari peserta di lokasi dalam dan sekitar Edison (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Mengambil pesertaFasa 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
A Study of CRD3874-SI in People With Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauh
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Mengambil pesertaFasa 3
- Saint Peter's University Hospital, New Brunswick · 3 mi jauh
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauh
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Mengambil pesertaFasa 1/2
- Saint Peter's University Hospital, New Brunswick · 3 mi jauh
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi jauh
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Mengambil pesertaFasa 3
- Rutgers Biomedical and Health Sciences, New Brunswick · 3 mi jauh
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi jauh
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Study of Revumenib and Mezigdomide in People With Leukemia
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauh
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Mengambil pesertaFasa 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi jauh
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Mengambil pesertaFasa 1
- Rutgers Cancer Institute, New Brunswick · 3 mi jauh
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi jauh
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi jauh
Kajian Leukemia Mieloid Akut di bandar lain
- Houston, TX85 kajian
- New York City, NY51 kajian
- Boston, MA44 kajian
- Baldwin Park, CA40 kajian
- Seattle, WA40 kajian
- Columbus, OH35 kajian
- Philadelphia, PA34 kajian
- Durham, NC33 kajian
- Atlanta, GA30 kajian
- Tampa, FL29 kajian
- Chicago, IL26 kajian
- Portland, OR25 kajian
Kajian lain di Edison
- Kanser Payudara68 kajian
- Kanser Paru-paru Bukan Sel Kecil47 kajian
- Kanser (semua jenis)33 kajian
- Kanser Prostat29 kajian
- Kanser Kolorektal23 kajian
- Kanser Paru-paru23 kajian
- Mieloma Pelbagai22 kajian
- Kanser Pundi Kencing21 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari20 kajian
- Kanser Endometrium19 kajian
- Karsinoma Urotelial (Sel Transisi)18 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.